Jim Appleman

Jim Appleman

Company: Primmune Therapeutics

Job title: Chief Scientific Officer, Co- Founder, Director & Senior Vice President - Research & Development


Breakfast Panel Discussion: How Far Have We Come & Where Do We Want to Go? 9:30 am

Dissecting the recent advances in PRR-targeting drugs Sharing insights into the directions for more successful immune system manipulation Thoughts on modes of action being investigated, conclusions drawn from setbacks and ways to improve the clinical outcomes Pathway understanding, indications, toxicity outlooks, combinations, drug formats and delivery mechanisms Biological understanding update: pathway, biomarker and translational updates…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.